| No. | Recommendation | GoR | LoE | Sources |
|---|---|---|---|---|
| 3.4 | An increased risk of developing endometrial cancer was observed following the long-term administration of continuous combined hormone therapy > 6 years or > 10 years. | ST | 3 | 9 , 10 |
| 3.5 | The administration of progesterone or dydrogesterone in the context of continuous combined hormone therapy may increase the risk of developing endometrial cancer. | ST | 3 | 13 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.